Cholangiocarcinoma
About
Mappings
NCI Thesaurus: Cholangiocarcinoma (coding:ncit:C4436)
OncoTree: Cholangiocarcinoma (coding:oncotree:CHOL)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | FGFR2::v | Cholangiocarcinoma | Infigratinib | |
| FDA (2) HC (1) | IDH1 p.R132C | Cholangiocarcinoma | Ivosidenib | |
| FDA (2) HC (1) | IDH1 p.R132G | Cholangiocarcinoma | Ivosidenib | |
| FDA (2) HC (1) | IDH1 p.R132H | Cholangiocarcinoma | Ivosidenib | |
| FDA (2) HC (1) | IDH1 p.R132L | Cholangiocarcinoma | Ivosidenib | |
| FDA (2) HC (1) | IDH1 p.R132S | Cholangiocarcinoma | Ivosidenib | |
| FDA (2) HC (1) | FGFR2::v | Cholangiocarcinoma | Pemigatinib | |
| FDA (2) HC (1) | FGFR2 rearrangements | Cholangiocarcinoma | Pemigatinib | |
| FDA (2) | HER2-positive | Cholangiocarcinoma | Zanidatamab | |
| FDA (2) | v::NRG1 | Cholangiocarcinoma | Zenocutuzumab |